Breakthrough in brain cancer: China-US team unveils new drug
In a groundbreaking collaboration, scientists from China’s Renmin Hospital and Yale University have developed a promising treatment for glioblastoma, the deadliest brain cancer.
Their research, published in the journal Small Science, highlights nanoparticles capable of identifying and attacking tumor cells in mice.
The innovation uses something called bardoxolone that successfully penetrated the blood-brain barrier, which has been a key challenge in treating brain cancers.
This new drug disrupts crucial molecular processes that allow glioblastoma cells to grow, offering renewed hope for patients facing this aggressive form of cancer.
With clinical trials expected soon, the discovery could mark a major step forward in treating glioblastoma.